If you could inject yourself with a substance that purports to make you tanner, fitter, and healthier, would you? Many people ...

Semaglutide, a glucagon-like peptide-1 receptor agonist, has been shown to reduce the risk of adverse cardiovascular events in patients with diabetes. Whether semaglutide can reduce cardiovascular ...

GHRH receptor signaling sits at an intersection of hypothalamic peptide signaling, pituitary secretory dynamics, and broader endocrine feedback logic that shapes downstream metabolic programs in many ...

Some peptides help promote weight loss by helping to regulate blood sugar levels, metabolism, and appetite. These medications may cause side effects and people must have a prescription to take them.

Glucagon-like peptide-1 (GLP-1) receptor agonists -- your patients are on them, and perhaps you are too (or at least have thought about it). In 2023, more than 500 million people worldwide were ...

Glucagon-like peptide-1 receptor agonists and incidence of obesity-related cancer in adults with diabetes: A target-trial emulation study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...